In this issue:
Momelotinib vs. danazol in symptomatic anaemia and MF
Peptide-based vaccine for myeloproliferative neoplasms
Continuous infusion nelarabine for relapsed/refractory lymphoid malignancies
Pregnancy outcomes in SCD vs. anaemia
Itacitinib monotherapy for low-risk acute GVHD
T-cell changes after allogeneic SCT predict relapse and survival
Ruxolitinib for newly-diagnosed polycythaemia vera
Nutrition in haematological malignancy ICU patients with acute respiratory failure
Cause of death and excess mortality in lower-risk MDS
Immunosuppression and eculizumab use in PNH
Please login below to download this issue (PDF)